Helix BioPharma Corp. (TSX:HBP)
1.480
+0.030 (2.07%)
Sep 9, 2025, 3:01 PM EDT
Helix BioPharma Employees
Helix BioPharma had 7 employees as of July 31, 2024. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
n/a
Profits / Employee
-1.36M CAD
Market Cap
110.75M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 7 | -2 | -22.22% |
Jul 31, 2023 | 9 | 2 | 28.57% |
Jul 31, 2022 | 7 | -3 | -30.00% |
Jul 31, 2021 | 10 | -1 | -4.76% |
Jul 31, 2020 | 11 | -8 | -41.67% |
Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Curaleaf Holdings | 5,519 |
Green Thumb Industries | 4,800 |
Trulieve Cannabis | 6,000 |
Sienna Senior Living | 12,263 |
dentalcorp Holdings | 10,200 |
Cronos Group | 459 |
WELL Health Technologies | 1,507 |
Extendicare | 23,000 |
Helix BioPharma News
- 10 hours ago - Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025 - TheNewswire
- 4 days ago - Helix BioPharma Concludes Review, Will Not Proceed with Proposed Equity Draw-Down Subscription Facility with GEM - TheNewswire
- 18 days ago - Helix Biopharma Corp. Announces Closing of Private Placement, in Preparation for Institutional Investment and NASDAQ Uplisting - TheNewswire
- 27 days ago - Helix Biopharma Corp. Announces Publication in Frontiers in Oncology on the Effects of L-DOS47 as Monotherapy in NSCLC - TheNewswire
- 3 months ago - Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 2025 - TheNewswire
- 3 months ago - Helix BioPharma Corp. Announces CFO Appointment to Support Strategic Growth and Upcoming Milestones - TheNewswire
- 4 months ago - Helix BioPharma (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") Secures Pre-IND Candidates LEUMUNA(TM) and GEMCEDA(TM) in Strategic Acquisition from the Laevoroc Group - TheNewswire
- 4 months ago - Helix BioPharma Corp. (HBP.TO) Signs Capital Raising Agreement with Kerentech Consulting Ltd. - TheNewswire